Nonendemic HPV-Positive Nasopharyngeal Carcinoma: Association With Poor Prognosis

• Published in: International journal of radiation oncology, biology, physics Vol. 88; no. 3; pp. 580 - 588
• Main Authors: Stenmark, Matthew H., MD, McHugh, Jonathan B., MD, Schipper, Matthew, PhD, Walline, Heather M., MA, Komarck, Christine, BS, Feng, Felix Y., MD, Worden, Francis P., MD, Wolf, Gregory T., MD, Chepeha, Douglas B., MD, Prince, Mark E., MD, Bradford, Carol R., MD, Mukherji, Suresh K., MD, Eisbruch, Avraham, MD, Carey, Thomas E., PhD
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01-03-2014
• Subjects: Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma; CARCINOMAS; Child; COMPARATIVE EVALUATIONS; DIAGNOSIS; Disease-Free Survival; Epstein-Barr virus; Female; HAZARDS; Hematology, Oncology and Palliative Medicine; Herpesvirus 4, Human - genetics; Herpesvirus 4, Human - isolation & purification; Human papillomavirus; Humans; IN-SITU HYBRIDIZATION; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms - ethnology; Nasopharyngeal Neoplasms - mortality; Nasopharyngeal Neoplasms - virology; ONCOGENIC VIRUSES; Papillomaviridae - genetics; Papillomaviridae - isolation & purification; Papillomavirus Infections - ethnology; Papillomavirus Infections - mortality; Papillomavirus Infections - virology; PATIENTS; Prognosis; Radiology; RADIOLOGY AND NUCLEAR MEDICINE; RNA; RNA, Viral - isolation & purification; Young Adult
• ISSN: 0360-3016; 1879-355X
• DOI: 10.1016/j.ijrobp.2013.11.246

Purpose To investigate the relationship between human papillomavirus (HPV) and Epstein-Barr virus (EBV) in nonendemic nasopharyngeal carcinoma (NPC) and assess the prognostic implications of viral status. Methods and Materials Paraffin-embedded tumor specimens from 62 patients with primary NPC diagnosed between 1985 and 2011 were analyzed for EBV and high-risk HPV. EBV status was determined by the use of in situ hybridization for EBV encoded RNA. HPV status was assessed with p16 immunohistochemistry and multiplex polymerase chain reaction MassArray for determination of HPV type. Proportional hazards models were used to compare the risk of death among patients as stratified by viral status. Results Of 61 evaluable tumors, 26 (43%) were EBV-positive/HPV-negative, 18 (30%) were HPV-positive/EBV-negative, and 17 (28%) were EBV/HPV-negative. EBV and HPV infection was mutually exclusive. HPV positivity was significantly correlated with World Health Organization grade 2 tumors, older age, and smoking (all P <.001). The racial distribution of the study population was 74% white, 15% African American, and 11% Asian/Middle Eastern. Among HPV-positive patients, 94% were white. At a median follow-up time of 7 years, HPV-positive and EBV/HPV-negative tumors exhibited worse outcomes than did EBV-positive tumors, including decreased overall survival (hazard ratio [HR] 2.98, P =.01; and HR 3.89, P =.002), progression-free survival (HR 2.55, P =.02; and HR 4.04, P <.001), and locoregional control (HR 4.01, P =.03; and HR 6.87, P =.001). Conclusion In our Midwestern population, high-risk HPV infection may play an etiologic role in the development of nonendemic, EBV-negative NPC. Compared with EBV-positive NPC, HPV-positive and EBV/HPV-negative NPC are associated with worse outcomes. A larger confirmatory study is needed to validate these findings.